Dr. Abraham Morgentaler

And so there's a lot of men that sort of fall outside the system. They just stop their ADT. They're lost to the system. And I'm not saying they should all go on testosterone. So I don't believe that ADT is bad or that it's dangerous. And in the proper circumstances with informed consent, I think it's totally the appropriate thing. But there is a cost.

And so there's a lot of men that sort of fall outside the system. They just stop their ADT. They're lost to the system. And I'm not saying they should all go on testosterone. So I don't believe that ADT is bad or that it's dangerous. And in the proper circumstances with informed consent, I think it's totally the appropriate thing. But there is a cost.

And so there's a lot of men that sort of fall outside the system. They just stop their ADT. They're lost to the system. And I'm not saying they should all go on testosterone. So I don't believe that ADT is bad or that it's dangerous. And in the proper circumstances with informed consent, I think it's totally the appropriate thing. But there is a cost.

And sometimes the cost is often decreased quality of life. As a rule, almost everybody that I treated with advanced prostate cancer who came to me and wanted testosterone, they almost all said the same thing, which is that this life that I'm leading now, it doesn't feel like much of a life. And even if it shortens my life, I'd like to live better.

And sometimes the cost is often decreased quality of life. As a rule, almost everybody that I treated with advanced prostate cancer who came to me and wanted testosterone, they almost all said the same thing, which is that this life that I'm leading now, it doesn't feel like much of a life. And even if it shortens my life, I'd like to live better.

And sometimes the cost is often decreased quality of life. As a rule, almost everybody that I treated with advanced prostate cancer who came to me and wanted testosterone, they almost all said the same thing, which is that this life that I'm leading now, it doesn't feel like much of a life. And even if it shortens my life, I'd like to live better.

And that was the justification for them wanting to go on testosterone.

And that was the justification for them wanting to go on testosterone.

And that was the justification for them wanting to go on testosterone.

Yeah. So I treat them as a normal patient because it's a little bit like you can't be a little pregnant. You either are or you're not. The fear, it's taken me 30, 35 years to come to the conclusion that I have around testosterone and prostate cancer. And it took me a long time. And I don't expect people to have a sudden epiphany about it.

Yeah. So I treat them as a normal patient because it's a little bit like you can't be a little pregnant. You either are or you're not. The fear, it's taken me 30, 35 years to come to the conclusion that I have around testosterone and prostate cancer. And it took me a long time. And I don't expect people to have a sudden epiphany about it.

Yeah. So I treat them as a normal patient because it's a little bit like you can't be a little pregnant. You either are or you're not. The fear, it's taken me 30, 35 years to come to the conclusion that I have around testosterone and prostate cancer. And it took me a long time. And I don't expect people to have a sudden epiphany about it.

So there's no difference in terms of what we were taught about risk, whether you give a little testosterone or normal amounts of testosterone. It was supposed to be dangerous no matter how much you gave. So you may as well just treat them. And what kind of treatment you give matters. It's sort of what the doctor's comfortable with.

So there's no difference in terms of what we were taught about risk, whether you give a little testosterone or normal amounts of testosterone. It was supposed to be dangerous no matter how much you gave. So you may as well just treat them. And what kind of treatment you give matters. It's sort of what the doctor's comfortable with.

So there's no difference in terms of what we were taught about risk, whether you give a little testosterone or normal amounts of testosterone. It was supposed to be dangerous no matter how much you gave. So you may as well just treat them. And what kind of treatment you give matters. It's sort of what the doctor's comfortable with.

I think some people may be more comfortable with gel initially because the levels don't get as high. You can stop it if the PSA goes up and it makes you nervous, then you can stop it. But once you have a little comfort with it, and the easiest patients to start with are the people who had lower risk prostate cancer before definitive treatment, Gleason 6 or Gleason 3 plus 4.

I think some people may be more comfortable with gel initially because the levels don't get as high. You can stop it if the PSA goes up and it makes you nervous, then you can stop it. But once you have a little comfort with it, and the easiest patients to start with are the people who had lower risk prostate cancer before definitive treatment, Gleason 6 or Gleason 3 plus 4.

I think some people may be more comfortable with gel initially because the levels don't get as high. You can stop it if the PSA goes up and it makes you nervous, then you can stop it. But once you have a little comfort with it, and the easiest patients to start with are the people who had lower risk prostate cancer before definitive treatment, Gleason 6 or Gleason 3 plus 4.

maybe with negative margins, undetectable PSA afterwards, or even radiation therapy, again, with lower risk disease. And I think once you start seeing that lightning does not strike either the doctor down or the patient, that people get more comfortable. Amazing thing happened to me, which is, so at this past year's AUA, I moderated a plenary session.

maybe with negative margins, undetectable PSA afterwards, or even radiation therapy, again, with lower risk disease. And I think once you start seeing that lightning does not strike either the doctor down or the patient, that people get more comfortable. Amazing thing happened to me, which is, so at this past year's AUA, I moderated a plenary session.